Niels Obel - Infectious Diseases

Author Information

Niels Obel is a renowned researcher affiliated with the Department of Infectious Diseases at Copenhagen University Hospital, Rigshospitalet, in Copenhagen, Denmark. His work primarily focuses on infectious diseases, and he has made significant contributions to understanding various health conditions, especially in the context of HIV and related complications.

Research Contributions

Niels Obel has an extensive research portfolio, with a notable focus on infectious diseases and their broader implications on public health. He has conducted numerous studies on the risk factors and outcomes associated with HIV, including the impact of antiretroviral therapy on birth outcomes and the incidence of other conditions such as tuberculosis and chronic obstructive pulmonary disease in people living with HIV. His work also extends to studies on COVID-19 treatment and outcomes, as well as other significant health issues like brain abscesses, cancer, and sarcoidosis, highlighting his diverse research interests and contributions to the field of infectious diseases.

Aliases

Niels Obel may also be referred to by other names such as N Obel and N. Obel in various publications and research databases.

Publication and Citation Metrics

Metric	Value
Citation Count	13,314
h-index	55
Paper Count	390

Publications:

Observed Protection Against SARS-CoV-2 Reinfection Following a Primary Infection: A Danish Cohort Study Using Two Years of Nationwide PCR-Test Data

DOI: 10.2139/ssrn.4054807

Year: 2022

Socioeconomic functioning in patients with brain abscess - a nationwide, population-based cohort study in Denmark.

DOI: 10.1016/j.jinf.2022.02.017

Year: 2022

Risk of subarachnoid haemorrhages and aneurysms in Danish People Living With HIV, a nationwide cohort study.

DOI: 10.1097/QAD.0000000000003260

Year: 2022

Use of antiretroviral therapy in pregnancy and association with birth outcome among women living with HIV in Denmark: A nationwide, population-based cohort study.

DOI: 10.1111/hiv.13304

Year: 2022

Risk of Cancer Among Sarcoidosis Patients With Biopsy-verified Nonnecrotizing Granulomatous Inflammation: Population-based Cohort Study

DOI: 10.3899/jrheum.210588

Year: 2022

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.

DOI: 10.1080/10428194.2021.2023741

Year: 2022

Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study.

DOI: 10.1093/cid/ciac243

Year: 2022

Risk of infections and mortality in Danish patients with cancer diagnosed with bone metastases: a population-based cohort study

DOI: 10.1136/bmjopen-2021-049831

Year: 2021

Tuberculosis incidence and mortality in people living with HIV: A Danish nationwide cohort study.

DOI: 10.1016/j.cmi.2021.07.036

Year: 2021

Incidence of chronic obstructive pulmonary disease in people with HIV, their parents and siblings in Denmark.

DOI: 10.1093/infdis/jiab369

Year: 2021

What are the Symptoms in Humans?

What Are the Components of the DTaP Vaccine?

How Does the NIH Support Global Health?

How is HTS Applied in Infectious Diseases?

What is the Treatment for E. Coli Infection?

How Do Pathogens Utilize Fatty Acid Biosynthesis?

What Role Does the Immune System Play?

What Are the Challenges in Controlling Aedes Aegypti?

What is Veterinary Medicine?

What Are the Outcomes of Host-Pathogen Interactions?

Partnered Content Networks

Relevant Topics